Tvardi Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

TVRD

organization

SIC: 2834

SEC Insider

$49.4M

545 transactions

Summary

Tvardi Therapeutics, Inc. (TVRD) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $19.3MSales: $28.2M46 insiders

Date	Insider	Type	Value
2026-06-09	WYZGA MICHAEL S	A	$0
2026-06-09	Shah Sujal	A	$0
2026-06-09	Smith Cynthia	A	$0
2026-06-09	HALL WALLACE L JR	A	$0
2026-06-09	Shiff Susan Ph.D.	A	$0
2026-01-29	Kauh John Saewook M.D.(Chief Medical Officer)	A	$0
2026-01-29	Alibhai Imran Nizamudin(Chief Executive Officer)	A	$0
2026-01-29	O'Brien Stephen Paul(Principal Accounting Officer)	A	$0
2026-01-29	Conn Avi Daniel(Chief Financial Officer)	A	$0
2025-12-16	Kauh John Saewook M.D.(Chief Medical Officer)	A	$0
2025-12-16	Alibhai Imran Nizamudin(Chief Executive Officer)	A	$0
2025-12-16	O'Brien Stephen Paul(Principal Accounting Officer)	A	$0
2025-12-16	Conn Avi Daniel(Chief Financial Officer)	A	$0
2025-07-07	Tweardy Samuel David	J	$0
2025-07-07	Tweardy Samuel David	J	$0
2025-04-17	HALL WALLACE L JR	A	$0
2025-04-17	Shah Sujal	A	$0
2025-04-17	Smith Cynthia	A	$0
2025-04-17	WYZGA MICHAEL S	A	$0
2025-04-17	Wirk Shaheen	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Tvardi Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope